Go Pro

Canopy Growth (CGC) Competitors

Canopy Growth logo
$1.00 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$1.00 +0.00 (+0.50%)
As of 07/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

Should you buy Canopy Growth stock or one of its competitors? MarketBeat compares Canopy Growth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Canopy Growth compare to Aurora Cannabis?

Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and valuation.

In the previous week, Canopy Growth had 7 more articles in the media than Aurora Cannabis. MarketBeat recorded 9 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.68 beat Canopy Growth's score of 0.27 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Aurora Cannabis
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Aurora Cannabis has a net margin of -33.57% compared to Canopy Growth's net margin of -75.27%. Aurora Cannabis' return on equity of 0.10% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-75.27% -26.95% -17.20%
Aurora Cannabis -33.57%0.10%0.07%

Canopy Growth has a beta of 0.79, suggesting that its share price is 21% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

Aurora Cannabis has lower revenue, but higher earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$251.01M1.79-$190.29M-$0.59N/A
Aurora Cannabis$247.82M0.70-$88.13M-$1.56N/A

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Canopy Growth beats Aurora Cannabis on 9 of the 15 factors compared between the two stocks.

How does Canopy Growth compare to Cronos Group?

Canopy Growth (NASDAQ:CGC) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

Canopy Growth has a beta of 0.79, meaning that its stock price is 21% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

In the previous week, Canopy Growth had 6 more articles in the media than Cronos Group. MarketBeat recorded 9 mentions for Canopy Growth and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.55 beat Canopy Growth's score of 0.27 indicating that Cronos Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cronos Group
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.2% of Canopy Growth shares are held by insiders. Comparatively, 7.8% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cronos Group has a net margin of -1.14% compared to Canopy Growth's net margin of -75.27%. Cronos Group's return on equity of -1.26% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-75.27% -26.95% -17.20%
Cronos Group -1.14%-1.26%-1.20%

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 19.58%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
Cronos Group
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Cronos Group has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$251.01M1.79-$190.29M-$0.59N/A
Cronos Group$146.59M7.28-$9.45M$0.01286.00

Summary

Cronos Group beats Canopy Growth on 13 of the 15 factors compared between the two stocks.

How does Canopy Growth compare to Organigram Global?

Organigram Global (NASDAQ:OGI) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Organigram Global
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Canopy Growth
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17

Organigram Global has a net margin of -9.22% compared to Canopy Growth's net margin of -75.27%. Organigram Global's return on equity of -13.41% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Organigram Global-9.22% -13.41% -9.09%
Canopy Growth -75.27%-26.95%-17.20%

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 3.3% of Canopy Growth shares are held by institutional investors. 0.1% of Organigram Global shares are held by insiders. Comparatively, 0.2% of Canopy Growth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Organigram Global has higher earnings, but lower revenue than Canopy Growth. Organigram Global is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organigram Global$185.07M0.78-$17.70M-$0.13N/A
Canopy Growth$251.01M1.79-$190.29M-$0.59N/A

Organigram Global has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market.

In the previous week, Canopy Growth had 9 more articles in the media than Organigram Global. MarketBeat recorded 9 mentions for Canopy Growth and 0 mentions for Organigram Global. Canopy Growth's average media sentiment score of 0.27 beat Organigram Global's score of 0.00 indicating that Canopy Growth is being referred to more favorably in the news media.

Company Overall Sentiment
Organigram Global Neutral
Canopy Growth Neutral

Summary

Organigram Global beats Canopy Growth on 8 of the 14 factors compared between the two stocks.

How does Canopy Growth compare to SNDL?

SNDL (NASDAQ:SNDL) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

SNDL currently has a consensus price target of $5.00, indicating a potential upside of 263.64%. Given SNDL's higher probable upside, research analysts plainly believe SNDL is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Canopy Growth
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17

SNDL has a net margin of -1.19% compared to Canopy Growth's net margin of -75.27%. SNDL's return on equity of -1.02% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
SNDL-1.19% -1.02% -0.85%
Canopy Growth -75.27%-26.95%-17.20%

3.3% of Canopy Growth shares are held by institutional investors. 0.2% of Canopy Growth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SNDL$677.32M0.52-$11.29M-$0.03N/A
Canopy Growth$251.01M1.79-$190.29M-$0.59N/A

SNDL has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.79, suggesting that its stock price is 21% less volatile than the broader market.

In the previous week, Canopy Growth had 8 more articles in the media than SNDL. MarketBeat recorded 9 mentions for Canopy Growth and 1 mentions for SNDL. Canopy Growth's average media sentiment score of 0.27 beat SNDL's score of 0.00 indicating that Canopy Growth is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SNDL
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Canopy Growth
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

SNDL and Canopy Growth tied by winning 8 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

In the previous week, Tilray Brands had 13 more articles in the media than Canopy Growth. MarketBeat recorded 22 mentions for Tilray Brands and 9 mentions for Canopy Growth. Tilray Brands' average media sentiment score of 0.32 beat Canopy Growth's score of 0.27 indicating that Tilray Brands is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
6 Very Positive mention(s)
1 Positive mention(s)
13 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Canopy Growth
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Tilray Brands has a beta of 1.89, suggesting that its share price is 89% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.79, suggesting that its share price is 21% less volatile than the broader market.

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by company insiders. Comparatively, 0.2% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Tilray Brands currently has a consensus price target of $11.50, indicating a potential upside of 148.92%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25
Canopy Growth
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17

Canopy Growth has lower revenue, but higher earnings than Tilray Brands. Canopy Growth is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$821.31M0.66-$2.19B-$13.65N/A
Canopy Growth$251.01M1.79-$190.29M-$0.59N/A

Canopy Growth has a net margin of -75.27% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-156.51% -3.31% -2.42%
Canopy Growth -75.27%-26.95%-17.20%

Summary

Tilray Brands beats Canopy Growth on 12 of the 16 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CGC vs. The Competition

MetricCanopy GrowthMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$448.42M$8.77B$7.18B$12.46B
Dividend YieldN/A2.45%2.67%6.49%
P/E Ratio-1.6916.5527.7524.70
Price / Sales1.797.45533.8298.65
Price / CashN/A18.1149.2657.09
Price / Book0.883.5310.966.46
Net Income-$190.29M$226.25M$3.57B$337.01M
7 Day Performance7.07%1.50%2.11%1.70%
1 Month Performance-3.85%-2.73%2.80%0.68%
1 Year Performance-22.78%-0.49%33.39%23.94%

Canopy Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CGC
Canopy Growth
1.2106 of 5 stars
$1.00
flat
N/A-22.8%$448.42M$251.01MN/A3,150
ACB
Aurora Cannabis
1.0879 of 5 stars
$2.87
-2.0%
N/A-37.9%$179.74M$247.82MN/A1,028
CRON
Cronos Group
1.2519 of 5 stars
$2.65
-2.2%
$2.30
-13.2%
+40.2%$1.01B$146.59M265.27450
OGI
Organigram Global
0.3585 of 5 stars
$0.96
-0.5%
N/A-27.5%$135.80M$185.07MN/A1,139
SNDL
SNDL
2.8426 of 5 stars
$1.40
-1.4%
$5.00
+257.1%
+7.8%$365.50M$677.32MN/A2,751

Related Companies and Tools


This page (NASDAQ:CGC) was last updated on 7/4/2026 by MarketBeat.com Staff.
From Our Partners